MYGN FY 2008 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$473M

FY 2008 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$327M-2.1% YoY

Gross Profit

$283M86.7% margin

Operating Income

$126M38.7% margin

Net Income

$85M25.9% margin

EPS (Diluted)

$0.86

Cash Flow

Operating Cash Flow

$84M

Free Cash Flow

$84M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$466M

Total Liabilities

$32M

Stockholders' Equity

$434M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$327M	$334M	-2.1%
Gross Profit	$283M	$301M	-6.0%
Operating Income	$126M	$38M	+232.1%
Net Income	$85M	$48M	+76.9%